Targeted therapies for CLL: new data and unanswered questions
The differences in treating older versus younger CLL patients
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
The importance of the collaboration of the solid and liquid tumor communities
Importance of Bcl-2-targeted therapies
John Gribben et al.